Luer activated device with minimal fluid displacement

Information

  • Patent Grant
  • 7753338
  • Patent Number
    7,753,338
  • Date Filed
    Monday, October 22, 2007
    17 years ago
  • Date Issued
    Tuesday, July 13, 2010
    14 years ago
Abstract
A luer activated device includes an inlet adapted to receive a male luer, an outlet associable with a fluid flow system, and a flow path defined therebetween. The inlet receives a resealable valve element having an aperture adapted to receive the male luer. The valve element is adapted such that a male luer inserted into the aperture will open fluid flow through the inlet without causing a substantial change in fluid displacement.
Description
FIELD OF THE INVENTION

The present invention relates generally to luer activated devices or valves that allow for the bi-directional transfer of fluids to and from medical fluid flow systems.


BACKGROUND OF THE INVENTION

Luer activated devices (LAD) or valves (LAV) are commonly used in association with medical fluid containers and medical fluid flow systems that are connected to patients or other subjects undergoing diagnostic, therapeutic or other medical procedures. A LAD can be attached to or part of a fluid container or a medical fluid flow system to simplify the addition of fluids to or withdrawal of fluids from the fluid flow system.


Within the medical field there are a wide variety of medical fluid flow systems, serving a variety of functions. One of the more common uses of LADs are in association with fluid flow systems that are used for the intravenous administration of fluids, such as saline, antibiotics, or any number of other medically-related fluids, to a patient. These flow systems are commonly referred to as intravenous or “IV” fluid administration sets, and use plastic tubing to connect a phlebotomized subject to one or more medical fluid sources, such as intravenous solution or medicament containers.


Typically, such intravenous administration sets include one or more LADs providing needless access to the fluid flow path to allow fluid to be added to or withdrawn from the IV tubing. The absence of a needle for injecting or withdrawing fluid has the important advantage of reducing the incidence of needle stick injuries to medical personnel. A LAD typically includes a tapered female luer component, such as the inlet into a valve housing, that accepts and mates with a tapered male luer of a medical infusion or aspiration device, such as a needleless syringe or a administration set tubing brand.


There are certain characteristics and qualities of LADs that are highly desirable. For example, the LAD should provide a sufficient microbial barrier for the full service life of the valve. It is desirable that the microbial barrier be conducive to the application of standard aseptic techniques preformed by clinicians during the use of the device. For example, the geometry of the LAD should be such that it is easily swabbable and reduces the potential of entrapping particulates or contaminants that cannot be cleanly swabbed clear prior to use.


Furthermore, it is highly desirable that the LAD be substantially devoid of any interstitial space or any other “dead space” that cannot be flushed, or that such interstitial space be physically isolated from the fluid flow path. Such interstitial space has the potential of providing an environment for undesired microbial growth. In addition, the LAD should have a geometry that allows it to be sufficiently flushed so as to clear the dynamic fluid path and adjacent areas of residual blood or intravenous fluids to prevent undesired clotting or microbial growth.


LAD's are commonly used with intravenous catheters that provide access to a patient's vascular system. In such systems, another desirable feature of a LAD is minimal displacement of fluid during insertion and removal of the male luer. In certain situations, it is preferable that the LAD be a neutral/neutral device in that there is zero or only a very slight displacement of fluid during both insertion and removal of the male luer. In other situations it can be desirable for the LAD to produce a positive displacement of fluid from the valve housing during the removal of the male luer. The LAD also preferably prevents blood reflux into the catheter. Reflux is known to reduce the efficiency of the catheter and contribute to catheter clotting.


In most situations it is preferred that the LAD be dimensioned to be completely activated by a wide range of ISO compliant male luer lock adaptors. However, there may be some instances when the LAD may be designed to be activated by a male luer connector that is not ISO complaint or is a male luer slip connector. Another desirable characteristic of a LAD is the ability of the LAD to seal against pressure contained within a fluid system to which the LAD is connected. For example, it is desirable to be leak resistance to positive pressures ranging from 10 to 45 psi and to negative pressures or vacuum from 1 to 5 psi. The LAD also preferably has a geometry that allows for easy priming and flushing that does not require any additional manipulations to remove residual air bubbles from the tubing system.


These and other desirable characteristics, which may be used separately or in various combinations, are preferably present over the full service life of the valve. When used in connection with an IV set or catheter, the LAD may go through many connections and disconnections. It is desirable that the life of a LAD last through upwards to about 100 connections and disconnections or 96 hours of dwell time.


As described more fully below, the fluid access devices of the present invention provide important advances in the safe and efficient administration or withdrawal of medical fluids to or from a fluid flow system.


SUMMARY OF THE INVENTION

In accordance with one aspect of the present invention, a luer activated medical valve for the bi-directional transfer of fluid therethrough is provided with a valve housing having an inlet adapted to receive a male luer, an outlet, and a flow path defined therebetween. A valve element is received within the inlet of the valve housing and includes a resealable aperture adapted to receive a male luer to allow fluid to be transferred between the male luer and the flow path. In accordance with one aspect of this invention, when the male luer is inserted or removed from the aperture, there is substantially no fluid displacement from or into the valve housing.





BRIEF DESCRIPTION OF THE DRAWINGS

Turning now to a more detailed description of the various embodiments of the present invention illustrated in the attached drawings, of which:



FIG. 1 is a cross-sectional view of one embodiment of a luer activated device having a valve element with a two-way blunt nose slit valve design;



FIG. 2 is a cross-sectional view of the LAD of FIG. 1, in an open condition



FIG. 3 is a cross-sectional view of an LAD having a valve element with a bi-directional umbrella valve, in a closed condition;



FIG. 4 is a cross-sectional view of the LAD of FIG. 3, with the umbrella valve in an open condition;



FIG. 5 is a cross-sectional view of a LAD having a valve element with two septa and an elastomeric spacer therebetween;



FIG. 6 is a cross-sectional view of the LAD of FIG. 5, in an open condition;



FIG. 7 is a cross-sectional view of a LAD having a valve element with a low pressure seal;



FIG. 8 is a cross-sectional view of the LAD of FIG. 7, with the low pressure seal in an open condition;



FIG. 9 is a cross-sectional view of a LAD having a valve element with two septa according to an aspect of the present invention;



FIG. 10 is a cross-sectional view of the LAD of FIG. 7, in an open condition;



FIG. 11 is a cross-sectional view of a LAD having a septa with a cusp valve;



FIG. 12 is a cross-sectional view of the LAD of FIG. 11, with the cusp valve in an open condition;



FIG. 13 is a cross-sectional view of a LAD having a valve element with a septum and a split-leg opening valve casing joined by a channel, in a closed condition;



FIG. 14 is a cross-sectional view of the LAD of FIG. 13, with the split-leg opening valve casing in an open condition;



FIG. 15 is a cross-sectional view of a LAD having a valve element with a split-leg opening valve casing, in a closed condition;



FIG. 16 is a cross-sectional view of the LAD of FIG. 15, with the split-leg opening valve casing in an open condition;



FIG. 17 is a cross-sectional view of a LAD having a valve element with a pair of void volumes;



FIG. 18 is a cross-sectional view of the LAD of FIG. 17, in an open condition;



FIG. 19 is a cross-sectional view of a LAD having a valve element with a barbed void volume arrow;



FIG. 20 is a cross-sectional view of the LAD of FIG. 19, in an open condition;



FIG. 21 is a cross-sectional view of a LAD having a valve element with a low pressure seal cap;



FIG. 22 is a cross-sectional view of the LAD of FIG. 21, in an open condition;



FIG. 23 is a cross-sectional view of a LAD having a valve element with a bellows chamber;



FIG. 24 is a cross-sectional view of the LAD of FIG. 23, in an open condition;



FIG. 25 is a cross-sectional view of a LAD having a torque-activated valve element;



FIG. 26 is a cross-sectional view of the LAD of FIG. 25, in an open condition;



FIG. 27 is a cross-sectional view of a LAD having a valve element with a stand pipe surrounded by an over sleeve;



FIG. 28 is a cross-sectional view of the LAD of FIG. 27, in an open condition;



FIG. 29 is a cross-sectional view of an alternate embodiment of the LAD of FIG. 5, in a closed condition;



FIG. 30 is a cross-sectional view of the LAD of FIG. 29, in an open condition;



FIG. 31 is a cross-sectional view of a LAD having a valve element with a plurality of sealing flanges;



FIG. 32 is a cross-sectional view of the LAD of FIG. 29, in an open condition;



FIG. 33 is a cross-sectional view of a LAD having a valve element with a cammed seal cap; and



FIG. 34 is a cross-sectional view of the LAD of FIG. 33, in an open condition.





DETAILED DESCRIPTION OF THE INVENTION

The embodiments disclosed herein are for the purpose of providing the required description of the present invention. These embodiment, however, are exemplary of the invention, which may be embodied in various forms. Therefore, specific details disclosed herein are not to be interpreted as limiting the invention as defined in the accompanying claims.



FIGS. 1 and 2 generally illustrates a first embodiment of a luer activated device (LAD) or valve of the present invention, generally designated as 10. The LAD 10 includes a valve housing 12 preferably comprised of a rigid material, such as rigid plastic or other suitable material. The LAD 10 may be provided as a unitary structure (not illustrated) or as a combination of a joined upper housing portion 14 and a lower housing portion 16. The LAD 10 also includes an inlet 18, an outlet 20, and a flow path 22 defined therebetween. The terms “inlet” and “outlet” are not to be interpreted as limiting the LAD 10 to applications involving fluid flow in a particular direction, e.g., from the inlet 18 to the outlet 20, because LAD's according to the present invention may be used in applications involving fluid flow from the inlet 18 to the outlet 20 or from the outlet 20 to the inlet 18.


The outlet 20 is adapted to be connected to any of a number of fluid flow systems, so the exact configuration of the outlet 20 will vary according to the nature of the fluid flow system to which it is to be connected. For example, the illustrated outlet 20 is suitable for use in connecting the valve 10 to an IV administrative tubing set (not illustrated). In the embodiment of FIG. 1, the outlet 20 may have a standard tapered male luer configuration and include a collar 24 defining an internal thread 26, which may be adapted to engage an external thread of the associated fluid flow system (not illustrated). Of course, the outlet 20 may be provided with a different configuration, a different locking system, or without a locking system, depending on the anticipated usage of the valve 10. Also, the valve 10 may be formed as an integral part of a larger structure without departing from the present invention.


The inlet 18 is adapted to receive a male connector such as a standard male luer 19 according to known structure and operation. The inlet 18 and male luer 19 preferably conform to ISO and/or ANSI standards. The male luer is generally tubular and preferably has a substantially smooth outer surface which is typically slightly tapered. The inlet 18 may include external threads 18a, in which case a portion of the connecting luer may be surrounded by a collar or skirt member (not illustrated) having internal threads adapted to removably lock the male luer to the inlet 18. Other attachment mechanisms, such frictional engagement with a tapered luer slip fit 19 may also be incorporated into LAD's according to the present invention.


To control flow through the housing 12, a valve system or element 28 is provided with a deformable upper seal or septum 30 defining a normally closed resealable first aperture 32 (preferably but not exclusively in the form of a slit) therethrough. The upper seal 30 is fixedly mounted to normally block and seal the inlet 18. A hollow blunt extension 34 extends downwardly from the upper seal 30 and communicates with the first aperture 32. Preferably, the extension 34 is comprised of a generally tubular portion 36, a generally conical or tapered portion 38, and a lower seal or septum portion 40 defining a generally blunt nose end with a second normally closed resealable aperture 42 therethrough. An internal chamber 44 is defined by the valve element 28 and connects the apertures 32 and 42. The chamber 44 is normally closed or isolated from the flow path 22 when the second aperture 42 is in a closed condition. The valve element 28 thus acts as a microbial barrier between the internal fluid flow path 22 of the LAD 10 and the atmosphere and substantially prevents fluid displacement when a luer is inserted into or removed from the LAD 10, as will be described in greater detail herein.


Preferably, the valve element 28 is molded as a unitary piece, typically from a deformable elastomeric material, such as silicone or rubber or Santoprene® thermoplastic, manufactured by Advanced Elastomer Systems, LP of Akron, Ohio. The valve element 28 may be fixedly attached to the inlet 18 by any of a number of means. Suitable means include, but are not limited to, adhesive or mechanical bonding and interference overmolding. At the inlet, the upper seal 30 preferably has a substantially flat or slightly outwardly curved outside surface that can be easily wiped with antiseptic, which aids in preventing contamination during use. The apertures 32 and 42 may be integrally formed, e.g., molded, with the seals 30 and 40 or may be formed after the valve element 28 is manufactured or seated within the inlet 18, such as by a slitting operation.


In use, a male luer 19 is inserted into the inlet 18 through the first aperture 32, which causes deformation of the valve element 28. The valve element 28 continues to deform as the luer is further inserted into the inlet 18 and, in a preferred embodiment, the lower seal portion 40 is adapted to deform and open the second aperture 42 substantially concurrently with full insertion of the male luer for insertion or withdrawal of liquid. To avoid fluid displacement as the luer is inserted into or removed from the inlet 18, upon full insertion of the male luer 19 the distance between the apertures 32 and 42 is preferably greater than the maximum extent to which the luer may be inserted into the inlet 18. By such a configuration, a fully inserted luer will remain almost wholly within the chamber 44. Accordingly, only a small portion of the luer may enter the LAD flow path 22 and decrease the available open volume, so fluid displacement upon insertion and removal of the luer is substantially neutralized.


In one embodiment, the blunt nose tubular portion 36 deforms outwardly by the force of the male luer to be in close proximity of the wall of the inlet 18, which reduces that volume of the LAD 10 as a possible fluid stagnation region or dead zone. While this tends to decrease the volume of the flow path 22, this change in volume is minor, especially compared to prior art valves which cause the luer to be fully inserted into the flow path, so fluid displacement with respect to the outlet 20 during insertion and removal of the luer is insignificant.



FIGS. 3 and 4 illustrate another embodiment of a LAD 100 according to the present invention. The LAD 100 includes a valve housing 102, an inlet 104, an outlet 106, and a flow path 108 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 110 is received within the inlet 104 to define a barrier between the flow path 108 and the outside environment. The valve element 110 comprises an upper seal 112 and a bi-directional umbrella disc or valve 114 spaced below the upper seal 112.


The upper seal 112 and umbrella valve 114 are deformable, with the upper seal 112 preferably comprising an elastomeric material having a relatively low durometer, such as silicone or rubber or Santoprene® elastomer, and the umbrella valve 114 comprising a more rigid but still flexible material, such as a relatively high durometer silicone.


The upper seal 112 defines a normally closed resealable aperture or slit 116 adapted to receive a male luer 118. The upper seal 112 preferably conforms generally to the description of the upper seal 30 of the embodiment of FIG. 1.


In the illustrated embodiment, the peripheral edge of the umbrella valve 114 seats on an annular shoulder 120 of the housing 102 and is maintained in place by stop means (not illustrated), but it may cooperate with alternative housing features, such as an annular channel or the like. The umbrella valve 114 is movable between a downwardly concave closed condition (FIG. 4) and an upwardly concave open condition (FIG. 4). In the closed condition, the umbrella valve 114 resembles a dome and seals fluid communication between the housing flow path 108 and the inlet 104. In the open condition of FIG. 4, the umbrella valve 114 reverses orientation to resemble a cup or saucer and unseats from the annular shoulder 120, thereby opening fluid communication between the housing flow path 108 and the inlet 104. Preferably, the umbrella valve 114 is resiliently biased to the closed condition, such that it will only assume the open condition upon application of an external influence or pressure and will automatically return to the closed condition upon removal of that influence. The transition from the closed condition to the open condition is preferably caused by contact with the male luer 118, as described in greater detail herein.


In use, the male luer 118 is initially inserted into the inlet 104 through the aperture 116. The luer 118 is further inserted until it contacts the umbrella valve 114 and moves the umbrella valve 114 to the open condition of FIG. 4. Preferably, the valve element 110 is adapted such that the umbrella valve 114 will move to the open condition substantially concurrently with the luer 118 being fully inserted into the inlet 104. With the umbrella valve 114 in the open condition, fluid flow may be achieved between the luer 118 and the LAD outlet 106. When the luer 118 is removed from the LAD 100, the umbrella valve 114 snaps back to the closed condition of FIG. 3, thereby closing fluid flow through the LAD 100.


It will be seen that the luer 118 remains above the umbrella valve 114 and outside of the LAD flow path 108 at all times, so the deflection and deformation of the umbrella valve 114 represents the only variation of the flow path 108 volume during insertion and removal of the luer 118. Accordingly, the volume of the flow path 108 remains substantially constant during use of the LAD 100, and fluid displacement upon insertion and removal of the luer 118 is substantially neutralized.



FIGS. 5 and 6 and 29 and 30 illustrates yet another LAD 200 according to the present invention. The LAD 200 includes a valve housing 202, an inlet 204, an outlet 206, and a flow path 208 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 210 is fixedly received within the inlet 204 to define a barrier between the flow path 208 and the outside environment. The valve element 210 comprises an upper seal 212, a lower seal 214, and a spacer member 216 intermediate the upper and lower seals 212 and 214. The valve element 210 acts as a microbial barrier between the internal fluid flow path 208 of the LAD 200 and the atmosphere and substantially prevents fluid displacement when a luer is inserted into or removed from the LAD 200, as will be described in greater detail herein.


Preferably, the valve element 210 is comprised of a deformable elastomeric material, such as silicone or rubber or Santoprene® material. The valve element 210 may be fixedly attached to the inlet 204 by any of a number of means. Suitable means include, but are not limited to, adhesive or mechanical bonding and interference overmolding. Preferably, the spacer member 216 is not affixed to the inlet 204, and may be separated therefrom by a gap or buffer (not illustrated) to allow outward radial movement and deformation of the spacer member 216.


The spacer member 216 may be composed of a foam 218, and referring particularly to FIGS. 5 and 6 may be pre-loaded with an antiseptic or anti-microbial gel or coating 220 to enhance infection control. The volume in which the space member 216 is received is sealed or closed at an upper end by a first resealable slit or aperture 222 in the upper seal 212 and at a lower end by a second resealable slit or aperture 224 in the lower seal 214.


In use, a male luer is inserted into the inlet 204 through the upper aperture 222, which causes deformation of the valve element 210. With the male luer partially inserted into the cavity 218, the spacer member 216 deforms downwardly and outwardly to contact the inlet wall. This deformation of the spacer member 216 is transmitted in part to the lower seal 214, but the lower seal 214 is preferably adapted such that the lower aperture 224 will not deform and open until the luer is fully inserted into the inlet 204.


In an embodiment, the lower seal 214 is sufficiently spaced from the upper seal 212 so that the luer cannot penetrate the lower aperture 224 and enter the LAD flow path 208. Hence, the lower aperture 224 is adapted to open primarily under influence of the deformable spacer member 216, rather than by primarily contact with the luer. When fluid transfer is complete and the luer is moved away from the inlet 204, the lower aperture 224 closes to minimize flow through the LAD 200 and reflux into the housing. As the valve element 210 is adapted to regulate fluid flow through the LAD 200 while minimizing the volume of the luer entering the LAD flow path 208, it will be appreciated that fluid displacement upon insertion and removal of the luer is substantially neutralized.



FIGS. 7-8, and 21-22 and 23-24 illustrate further embodiments of a LAD according to the present invention, generally designated as 300. The LAD 300 includes a valve housing 302, an inlet 304, an outlet 306, and a flow path 308 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 310 is fixedly received within the inlet 304 to define a barrier between the flow path 308 and the outside environment. The valve element 310 comprises a deformable upper seal or septum 312 defining a normally closed resealable first aperture or slit 314 therethrough. The upper seal 312 is comprised of an elastomeric material and fixedly mounted to normally block and seal the inlet 304.


A collapsible chamber 316 extends downwardly from the upper seal 312 and communicates with the upper aperture 314. The collapsible chamber 316 includes a collapsible wall 317 and may be comprised of a thermoplastic elastomeric material and includes a normally closed low cracking (opening) pressure bi-directional seal 318 that may be provided in any of a number of configurations. In the embodiment of FIG. 7, the low pressure seal 318 is provided as a slit, opening, or hole. In the embodiments of FIGS. 21-22 and 23-24, the low pressure seal 318b comprises a cap associated with the chamber 316 to provide the slit, opening, hole, valve, or other low pressure sealing means.


Regardless of the particular configuration of the low pressure seal, it is preferably adapted to open at a lower pressure than the upper aperture 314. For example, in the embodiment of FIG. 7-8, the upper aperture 314 is adapted to open at a pressure (or back pressure) of approximately 45 PSI, while the low pressure aperture 318 is adapted to open at a pressure (or back pressure) in the range of approximately 2-6 PSI.


Preferably, a male luer 301 fully inserted into the inlet 304 will be partially received within the chamber 316, but will not extend sufficiently to penetrate the low pressure seal 318 and enter the LAD flow path 308. Accordingly, fluid communication between the LAD inlet 304 and outlet 306 requires a luer 301 inserted into the inlet 304 (to open the upper aperture 314) and fluid flow from the luer or the system associated with the outlet 306 (to open the low pressure seal 318). When fluid flow through the LAD 300 ceases, the low pressure seal 318 will automatically move to a closed condition and the luer may be removed from the inlet 304. The chamber 316 may be treated with a lubricating material to permit easy release of the luer. Alternatively, the inner surface of the chamber 316 may be roughened or textured, as in a pleated bellows (FIGS. 7-8) of wall 317 to decrease the pull force required to remove the luer. As the valve element 310 is adapted to regulate fluid flow without allowing the male luer into the LAD flow path 308, fluid displacement upon insertion and removal of the luer is substantially neutralized.



FIGS. 9-10 and 11-12 illustrate two additional LADs 400 and 400a according to the present invention. The LAD 400, 400a includes a valve housing 402, an inlet 404, an outlet 406, and a flow path 408 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 410 is fixedly received within the inlet 404 to define a barrier between the flow path 408 and the outside environment. The valve element 410 comprises an upper seal 412 and a lower seal 414 spaced from each other. The upper seal 412 may be thinner than the lower seal 414 or thicker or have substantially the same thickness. It will be appreciated by those of ordinary skill in the art that the relative thicknesses of the two seals will result in varying performance characteristics, which allows the user to select a specific LAD according to his/her needs. The upper seal 412 includes a resealable upper aperture or slit 416. Referring particularly to FIGS. 9-10 the lower seal 414 includes a resealable lower aperture or slit 418. In the embodiment shown in FIGS. 11 and 12 the lower seal is formed in the configuration of a cusp valve 419. Preferably, the seals 412 and 414 and 419 are comprised of a deformable elastomeric material, such as silicone or rubber or Santoprene® elastomer. The seals 412 and 414 and 419 may be fixedly attached to the inlet 404 by any of a number of means. Suitable means include, but are not limited to, adhesive or mechanical bonding and interference overmolding.


The lower seal 414 is positioned such that a male luer fully inserted into the LAD inlet 404 will fully penetrate the aperture 416 of the upper seal 412, but only partially penetrate the aperture 418 of the lower seal 414. Preferably, the luer will contact the lower seal 414 and move the lower aperture 418 into an open condition substantially concurrently with full insertion of the luer. This may be preferred for a number of reasons. First, fluid flow through the LAD 400, 400a cannot begin until the luer is fully inserted into the inlet 404 and will cease as soon as the luer is moved away from the inlet 404. Second, by preventing the luer from protruding into the LAD flow path 408, fluid displacement during insertion and removal of the luer is substantially neutralized. Other advantages will be apparent to those of ordinary skill in the art.



FIGS. 15 and 16 illustrate a variation of the embodiments of FIGS. 9-12. The LAD 500 includes a valve housing 502, an inlet 504, an outlet 506, and a flow path 508 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 510 is fixedly received within the inlet 504 to define a barrier between the flow path 508 and the outside environment. The valve element 510 comprises an upper seal 512 and a lower seal 514 spaced from each other. In contrast to the embodiments of FIGS. 8A and 8B, the lower seal 514 is configured as a split-leg opening valve that is movable between a closed condition (FIG. 15) and an open condition (FIG. 16). The upper seal 512 includes a resealable upper aperture or slit 516 and the lower seal 514 includes a resealable lower aperture or slit 518. Preferably, the valve element 510 is comprised of a deformable elastomeric material, such as silicone or rubber or Santoprene® material. The seals 512 and 514 may be molded with the apertures 516 and 518 in place, or the apertures 516 and 518 may be later added by a slitting operation.


The lower seal 514 is a deformable, unitary structure comprised of a head portion 520 and a plurality of legs 522 extending downwardly from the head portion 520. The head portion 520 is sufficiently sized to form an interference fit with the inlet 504 in the closed condition of FIG. 9A. The inlet 504 may be provided with brackets, an annular rim, or other stop means (not illustrated) adapted to receive the head portion 520 and maintain the lower seal 514 in position. In the closed condition, the legs 522 are pressed together to seal the lower aperture 518 and block fluid flow through the LAD 500. When a luer 523 is fully inserted into the inlet 504, it will contact the lower seal 514, but not enter into the LAD flow path 508. The lower seal 514 is positioned and adapted such that contact from the fully inserted male luer will impart hoop forces that deform the lower seal 514, force the legs 522 apart, and open the lower aperture 518 (FIG. 9B) to allow fluid flow through the LAD 500. Preferably, the lower seal 514 is resiliently biased to the closed condition of FIG. 9A, such that moving the luer away from the inlet 504 will automatically close the lower aperture 518. As the valve element 510 is adapted to regulate fluid flow without allowing the male luer into the LAD flow path 508, fluid displacement upon insertion and removal of the luer is substantially neutralized.



FIGS. 13-14 illustrate variations of the embodiment of FIGS. 15-16. In particular, the valve elements 510a include a generally tubular channel 524 in communication with the upper aperture 516 and the lower aperture 518. In the illustrated embodiment, a portion of the channel 524 is received by the lower aperture 518, without opening the lower aperture 518. Hence, it will be appreciated that the channel 524 provides a direct conduit between the upper and lower apertures 516 and 518. In all other respects, the valve element 510a operates substantially similarly to the embodiment of FIGS. 15 and 16 in moving the lower seal 514 from a closed condition (FIG. 13) to an open condition (FIG. 14).



FIGS. 17 and 18 illustrate a LAD 600 having a valve housing 602, an inlet 604, an outlet 606, and a flow path 608 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 610 is comprised of an upper seal 612 and a lower seal 614 fixedly attached to the inlet 604. The upper seal 612 is preferably a septum-like member having an upper resealable aperture or slit 616 adapted to receive a male luer 617 inserted into the inlet 604. The upper seal 612 is substantially comprised of a deformable elastomeric material, such as silicone or rubber or Santoprene® elastomer.


The lower seal 614 can be understood as a generally tubular member with cup-shaped portions removed from its upper and lower ends to define an upper void volume 618 and a lower void volume 620. The volumes 618 and 620 are separated by a lower resealable aperture 622 that is movable between a closed condition (FIG. 17) and an open condition (FIG. 18). Preferably, the lower seal 614 is comprised of a compressible, deformable material. When used herein, the term “compressible” refers to a material that is capable of decreasing in volume by more than a nominal amount upon insertion of a male luer into the inlet 604. For example, a silicone or elastomeric material is deformable, because it will change shape to accommodate a male luer, but it is not compressible because it is not capable of a substantial reduction in volume. Those of ordinary skill in the art will appreciate that, when using known elastomeric slit septa, the open internal volume of the valve (i.e., the portion of the valve interior that is available for fluid flow) will substantially decrease upon insertion of a male luer, because the valve interior must receive the combined volumes of the male luer and the deformed valve element, instead of just the volume of the valve element. This change in open internal volume may impart a positive displacement of fluid through the outlet during the insertion of the male luer, which may be undesirable in certain applications. Hence, through the use of a compressible lower seal 614, the change in available flow path volume may be reduced or minimized to limit or avoid the effects of positive fluid displacement.


Preferably, the lower seal 614 is substantially comprised of a compressible polymeric foam with a closed-cell structure, such as a silicone or urethane foam. A closed-cell structure is typically more rigid and less compressible than an open-cell structure, so such a configuration may be preferred for ensuring a tight seal immediately before a male luer is fully inserted into the inlet 604 and immediately after the luer is removed therefrom. The lower seal 614 is preferably harder than the upper seal 612 (˜70-80 D vs. ˜40-50 D in one embodiment) to provide a relatively high pressure seal. The foam may also be treated with a lubricant or anti-microbial gel or liquid or any other performance-enhancing material.


In use, a male luer 617 is inserted into the inlet 604 and penetrates the upper aperture 616, thereby deforming the upper seal 612 and moving it partially into the upper void volume 618. The luer is further inserted into the inlet 604 and contacts the lower seal 614. Preferably, the lower seal 614 is positioned such that a fully inserted luer will enter into the lower aperture 622 without moving beyond the aperture 622 and entering the lower void volume 620 or LAD flow path 608. A luer so inserted will compress the lower seal 614 outwardly against the wall of the inlet 604 and open the lower aperture 622 to allow fluid flow through the LAD 600. As the valve element 610 is adapted to regulate fluid flow without allowing the male luer into the LAD flow path 608 or lower void volume 620, fluid displacement upon insertion and removal of the luer is substantially neutralized. The incidence of fluid displacement is even further minimized by the use of a compressible lower seal 614 that compresses outwardly, rather than deforming downwardly, as described previously herein.



FIGS. 19 and 20 illustrate yet another embodiment of a LAD according to the present invention, generally designated as 700. The LAD 700 includes a valve housing 702, an inlet 704, an outlet 706, and a flow path 708 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 710 is fixedly received within the inlet 704 to define a barrier between the flow path 708 and the outside environment. The valve element 710 comprises a deformable upper seal or septum 712 defining a resealable upper aperture or slit 714 therethrough. The upper seal 712 is fixedly mounted to normally block and seal the inlet 704. A barbed void volume arrow 716 extends downwardly from the upper seal 712 and communicates with the upper aperture 714. The barbed void volume arrow 716 includes a tapered portion 718 defining a lower aperture 720 that is movable between a closed condition (FIG. 19) and an open condition (FIG. 20). The external surface of the tapered portion 718 includes a plurality of radially projecting barbs 722 spaced from the wall of the inlet 704 in the closed condition and adapted to contact the wall when the lower aperture 720 is in the open condition. The barbs 722 may be provided as generally annular members to establish a circumferential seal between the tapered portion 718 and the inlet 704 in the condition of FIG. 20. This may be preferred to avoid the creation of a fluid stagnation region between the barbed void volume arrow 716 and the inlet 704 during fluid flow through the LAD 700.


Preferably, the valve element 710 is provided as a unitary piece, comprised of a deformable elastomeric material, such as silicone or rubber or Santoprene®. The upper seal 712 may be fixedly attached to the inlet 704 by any of a number of means. Suitable means include, but are not limited to, adhesive or mechanical bonding and interference overmolding.


In use, a male luer 723 is inserted into the inlet 704 and deforms the upper seal 712 to penetrate through the upper aperture 714. The male luer is further inserted into the inlet 704 to deform the barbed void volume arrow 716, thereby moving the barbs 722 against the housing 702 and opening the lower aperture 720. An additional benefit of the barbs 722 is realized during insertion of the luer into the inlet 704. As described previously herein, it may be preferred to cause the tapered portion 718 to contact the housing 702 and create a fluid seal. In comparison to a tapered portion 718 having a substantially smooth outer surface, a tapered portion 718 having a plurality of barbs 722 will minimize the compressive force generated when the lower aperture 720 opens and the barbed void volume arrow 716 is pressed against the inlet 704. Preferably, the valve element 710 is adapted such that a fully inserted luer will open the lower aperture 720 without extending into the flow path 708.


When fluid flow through the LAD 700 is completed, the luer is moved away from the inlet 704. Preferably, the tapered portion 718 is resiliently biased to the closed condition so that it will automatically close the lower aperture 720 when the luer is removed. By regulating fluid flow through the LAD 700 without requiring the luer to enter the LAD flow path 708, fluid displacement during insertion and removal of the luer is substantially neutralized.


The LAD 800 of FIGS. 25 and 26 includes a valve housing 802, an inlet 804, an outlet 806, and a flow path 808 generally according to the foregoing description of the embodiment of FIG. 1. An upper housing portion 810 is rotatably associated with a lower housing portion 812, such that the upper and lower housing portions may be rotated with respect to each other. This connection may be accomplished by any of a number of means, such as by way of an aligned rib and groove mechanism.


A valve element 814 is received within the inlet 804 and comprises an upper seal or septum 816 and a torque-activated valve 818 extending downwardly from the upper seal 816. The upper seal 816 is fixedly attached to the upper housing portion 810 and a lower section of the torque-activated valve 818 is fixedly attached to the lower housing portion 812. Hence, it will be appreciated that rotation of the upper housing portion 810 with respect to the lower housing portion 812 will impart torsion forces to the torque-activated valve 818.


The upper seal 816 defines a resealable aperture 820 in communication with a resealable lumen 822 of the torque-activated valve 818. The torque-activated valve 818 is preferably biased to a closed condition, wherein the lumen 822 is initially closed prior to rotation of the housing portions 810 and 812. When the housing portions 810 and 812 are rotated with respect to each other, the upper end of the torque-activated valve 818 is twisted with respect to the lower end to create a torsion force that opens the lumen 822. The lumen 822 remains open until the upper and lower housing portions 810 and 812 are returned to their original position relative to each other.


In contrast to the lumen 822 of the torque-activated valve 818, the aperture 820 of the upper seal 816 is not opened by rotation of the housing portions 810 and 812, but by insertion of a male luer 821 Accordingly, fluid flow through the LAD 800 cannot be achieved until a luer is inserted into the inlet 804 and the housing portions 810 and 812 are rotated with respect to each other.


A common system for locking a luer onto an LAD is to use mating threads, as described herein with respect to the embodiment of FIG. 1. Preferably, the valve element 814 is adapted to open as the luer is locked onto the inlet 804. In particular, a luer inserted into the inlet 804 will deform the upper seal 816 and penetrate through the aperture 820 to open the same. The lower housing portion 812 is gripped and a threaded collar of the luer (not illustrated) is rotated to mate with external threads 825 of the inlet 804). The upper housing portion 810 will tend to rotate as the luer is locked to the inlet 804, especially after the luer threads have been securely mated with the inlet threads, and the lumen 822 of the torque-activated valve 818 will be twisted and opened by the same motion. An unlocking rotation of the luer will have the opposite effect, thereby closing the lumen 822 and flow through the LAD 800 prior to removal of the luer from the inlet 804. It will be appreciated that the valve element 814 regulates flow through the LAD 800 without requiring the luer to enter the LAD flow path 808, so fluid displacement during insertion and removal of the luer is substantially neutralized.



FIGS. 27 and 28 illustrate still another embodiment of a LAD 900 according to the present invention. The LAD 900 includes a valve housing 902, an inlet 904, an outlet 906, and a flow path 908 generally according to the foregoing description of the embodiment of FIG. 1. In one embodiment, the housing 902 comprises an upper housing portion 910 secured to a lower housing portion 912. An upper end of the outlet 906 extends upwardly into the upper housing portion 910 to define a generally tubular stand pipe 914, which will be described in greater detail herein.


A valve element 916 is received within the inlet 904 to define a barrier between the flow path 908 and the outside environment. The valve element 916 comprises an upper seal 918 and a resealable over sleeve 920 surrounding the stand pipe 914. The upper seal 918 and over sleeve 920 are deformable, and preferably comprised of an elastomeric material, such as silicone or rubber or Santoprene® material.


The upper seal 918 defines a resealable upper aperture or slit 922 adapted to receive a male luer (not illustrated) and is preferably mechanically fixed within the upper housing portion 910.


The over sleeve 920 defines a lower aperture 924 and is movable between a closed condition (FIG. 27) and an open condition (FIG. 28). In the closed condition, the over sleeve 920 covers and blocks flow through the stand pipe 914. When a male luer 925 is inserted into the inlet 904, it penetrates through the upper aperture 922 and contacts the over sleeve 920. A fully inserted luer will push the over sleeve 920 down and around the stand pipe 914, thereby opening the lower aperture 924 and exposing the stand pipe 914 to allow flow through the LAD 900. When the luer is moved away from the inlet 904, the over sleeve 920 will resiliently return to the closed condition of FIG. 27, which closes the lower aperture 924 and prevents flow through the LAD 900. Hence, it will be seen that the valve element 916 regulates flow through the LAD 900 without allowing the luer to enter the LAD flow path 908, so fluid displacement upon insertion and removal of the luer is substantially neutralized.



FIGS. 31 and 32 illustrate another embodiment of a LAD 1000 according to the present invention. The LAD 1000 includes a valve housing 1002, an inlet 1004, an outlet 1006, and a flow path 1008 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 1010 is fixedly received within the inlet 1004 to define a barrier between the flow path 1008 and the outside environment. The valve element 1010 comprises an upper seal 1012 with a plurality of flexible sealing arms or flanges 1014 extending away from a bottom surface of the upper seal 1012. Preferably, the valve element 1010 is a unitary structure comprised of a deformable elastomeric material, such as silicone or rubber or Santoprene® elastomer.


The upper seal 1012 defines a resealable upper aperture or slit 1016 adapted to receive a male luer (not illustrated) and the sealing flanges 1014 meet at a point to define a resealable lower aperture 1018 movable between a closed condition (FIG. 31) and an open condition (FIG. 32). The sealing flanges 1014 may be substantially identical to each other or may have opposing thick and thin wall sections (not illustrated) having differing deformation properties, which may aid in opening and/or closing the lower aperture 1018.


The sealing flanges 1014 may have a generally “dogleg” configuration to define an open chamber 1020 in communication with the upper and lower apertures 1016 and 1018. In the closed condition of FIG. 31, the chamber 1020 is sealed off from the atmosphere (by the closed upper aperture 1016) and the LAD flow path 1008 (by the closed lower aperture 1018). Referring to FIG. 31, the upper aperture 1018 is opened by inserting a male luer 1025 into the inlet 1004 and deforming the upper seal 1012. The lower aperture 1018 will move to an open condition (FIG. 32) when the luer 1025 is fully inserted into the inlet 1004. This may be achieved by at least two different means. First, the sealing flanges 1014 may be adapted to deform upon contact with a luer and to spread apart and open the lower aperture 1016 when the luer 1025 has been fully inserted. Alternatively, the sealing flanges 1014 may be relatively thin, such that they provide a low pressure seal at the lower aperture 1016 that is adapted to open upon fluid flow from the luer or from the system associated with the LAD outlet 1006.


Regardless of the nature of the lower aperture 1016, the valve element 1010 is preferably adapted such that a fully inserted luer will enter into the chamber 1020, but not the LAD flow path 1008. By confining the luer to the chamber 1020, it will not alter the open volume of the LAD flow path 1008, so fluid displacement upon insertion and removal of the luer is substantially neutralized.



FIGS. 33 and 34 illustrate yet another embodiment of a LAD according to the present invention, generally designated as 1100. The LAD 1100 includes a valve housing 1102, an inlet 1104, an outlet 1106, and a flow path 1108 generally according to the foregoing description of the embodiment of FIG. 1. A valve element 1110 is received within the inlet 1104 to define a barrier between the flow path 1108 and the outside environment. The valve element 1110 comprises a deformable upper seal or septum 1112 defining a resealable first aperture or slit 1114 therethrough. The upper seal 1112 is comprised of an elastomeric material and fixedly mounted to normally block and seal the inlet 1104. Preferably, the upper seal 1112 is comprised of a deformable elastomeric material, such as silicone or rubber or Santoprene® material and is fixedly attached to the inlet 1104 by any of a number of means. Suitable means include, but are not limited to, adhesive or mechanical bonding and interference overmolding.


A cammed seal cap 1116 is secured to a lower surface of the upper seal 1112 and extends downwardly therefrom. The seal cap 1116 is preferably comprised of a thermoplastic material and defines a lower aperture 1118 movable between a closed condition (FIG. 33) and an open condition (FIG. 34). The seal cap 1116 includes one or more inwardly projecting cam surfaces 1120. The cam surfaces 1120 have an inner diameter less than the outer diameter of a male luer 1125 adapted to be inserted into the LAD inlet 1104, such that a luer so inserted will penetrate through the upper aperture 1114 and bear against the cam surfaces 1120. The cam surfaces 1120 are pressed outwardly by the luer, which causes the seal cap 1116 to deform and opens the lower aperture 1118 to allow fluid flow through the LAD 1100. Preferably, the valve element 1110 is adapted such that a fully inserted luer 1125 will open the lower aperture 1118 without penetrating the lower aperture 1118 and entering the LAD flow path 1108. As the valve element 1110 is adapted to regulate fluid flow without allowing the male luer into the LAD flow path 1108, fluid displacement upon insertion and removal of the luer is substantially neutralized.


While the present invention has been described in terms of certain preferred and alternative embodiments for purposes of illustration, it is not limited to the precise embodiments shown or to the particular features, shapes or sizes illustrated. A variety of changes may be made without departing from the present invention as defined by the appended claims.

Claims
  • 1. A medical valve for the bi-directional transfer of fluid, comprising: a valve housing having an inlet adapted to receive a male luer, an outlet, and a flow path defined therebetween; anda valve element closing the inlet of the valve housing, said valve element including a first and second normally closed resealable apertures, the first aperture having a higher opening pressure than the second aperture, the first and second apertures surrounding a space adapted to receive a male luer to allow fluid to be transferred between the male luer and the flow path, wherein there is substantially no fluid displacement when at least a portion of the male luer is inserted into or removed from the space, and wherein the second aperture is opened via pressure from a fluid introduced at the fluid outlet.
  • 2. The medical valve of claim 1, which includes a septum closing the inlet of the valve housing, the septum defining the first aperture, and a seal spaced apart from the septum, the seal defining the second aperture.
  • 3. The medical valve of claim 2, wherein the seal is spaced apart from the septum by a collapsible wall.
  • 4. The medical valve of claim 2, wherein the seal is a cap fitted to a wall extending from the septum.
  • 5. The medical valve of claim 2, wherein the seal is spaced apart from the septum such that the seal is unpenetrated by the male when fully inserted into the valve housing.
  • 6. The medical valve of claim 1, wherein the higher opening pressure is multiple times greater than the lower opening pressure.
  • 7. The medical valve of claim 1, wherein the second aperture closes automatically upon completion of fluid transfer through the medical valve.
  • 8. The medical valve of claim 7, the valve element configured to ease removal of the male luer after automatic closing of the second aperture.
  • 9. The medical valve of claim 8, wherein the valve element is lubricated to ease male luer removal.
  • 10. The medical valve of claim 8, wherein the valve element is textured to ease male luer removal.
  • 11. A medical fluid valve for the bi-directional transfer of fluid, comprising: a valve housing having an inlet adapted to receive a male luer, an outlet, and a flow path defined therebetween; anda valve element including (i) a septum sealing the inlet, the septum defining a first aperture, (ii) a seal defining a second aperture, and (iii) a chamber wall separating the seal from the septum, the chamber wall constructed and arranged such that the male luer when fully received within the valve housing opens only the first aperture.
  • 12. The medical fluid valve of claim 11, wherein the chamber wall is collapsible to allow the wall to expand and unfold upon insertion of the male luer.
  • 13. The medical fluid valve of claim 11, wherein the chamber wall is stretchable to allow the male luer when fully received within the valve housing to open only the first aperture.
  • 14. The medical fluid valve of claim 11, wherein the chamber wall is elongated such that the male luer when fully received within the valve housing opens only the first aperture.
  • 15. The medical fluid valve of claim 11, wherein seal is radially sized to receive the entire tip of the male luer.
  • 16. The medical fluid volume of claim 11, wherein the seal is configured to allow the second aperture to be opened via pressure of fluid introduced at the valve housing outlet.
  • 17. A medical fluid valve for the bi-directional transfer of fluid, comprising: a valve housing having an inlet adapted to receive a male luer, an outlet, and a flow path defined therebetween; anda valve element including (i) a septum sealing the inlet, the septum defining a first aperture, (ii) a seal defining a second aperture, and (iii) a chamber wall separating the seal from the septum, the chamber wall constructed and arranged to allow the seal to be contacted by the male luer when fully inserted without piercing the seal.
  • 18. The medical fluid valve of claim 17, wherein the septum, seal and chamber wall define a male luer receiving space that allows fluid to be transferred between the male luer and the flow path, and which at least substantially prevents fluid displacement when the male luer is inserted into or removed from the space.
  • 19. The medical fluid valve of claim 18, wherein the seal is configured to allow the second aperture to be opened via pressure of fluid residing within the flow path.
  • 20. A medical valve for the bi-directional transfer of fluid, comprising: a valve housing having an inlet adapted to receive a male luer, an outlet, and a flow path defined therebetween; anda valve element closing the inlet of the valve housing, said valve element including a first and second normally closed resealable apertures, the first aperture having a higher opening pressure than the second aperture, the first and second apertures surrounding a space adapted to receive a male luer to allow fluid to be transferred between the male luer and the flow path, wherein there is substantially no fluid displacement when at least a portion of the male luer is inserted into or removed from the space, and wherein the second aperture closes automatically upon completion of fluid transfer through the medical valve.
  • 21. A medical valve for the bi-directional transfer of fluid, comprising: a valve housing having an inlet adapted to receive a male luer, an outlet, and a flow path defined;a valve element closing the inlet of the valve housing, said valve element including a first and second normally closed resealable apertures, the first aperture having a higher opening pressure than the second aperture, the first and second apertures surrounding a space adapted to receive a male luer to allow fluid to be transferred between the male luer and the flow path, wherein there is substantially no fluid displacement when at least a portion of the male luer is inserted into or removed from the space; andwhich includes a septum closing the inlet of the valve housing, the septum defining the first aperture, and a seal spaced apart from the septum, the seal defining the second aperture, and wherein the seal is spaced apart from the septum by a collapsible wall.
PRIORITY CLAIM

This application claims the benefit of U.S. Provisional Patent Application No. 60/862,502, filed Oct. 23, 2006, entitled “LUER ACTIVATED DEVICE WITH MINIMAL FLUID DISPLACEMENT”, the entire contents of which are hereby incorporated by reference and relied upon.

US Referenced Citations (460)
Number Name Date Kind
4176588 Baron Dec 1979 A
4334551 Pfister Jun 1982 A
4413462 Rose Nov 1983 A
4475548 Muto Oct 1984 A
4691929 Neumaier et al. Sep 1987 A
4928212 Benavides May 1990 A
4943896 Johnson Jul 1990 A
4946445 Lynn Aug 1990 A
4964855 Todd et al. Oct 1990 A
4973443 Larson et al. Nov 1990 A
4998713 Vaillancourt Mar 1991 A
4998927 Vaillancourt Mar 1991 A
5009490 Kouno et al. Apr 1991 A
5019325 Larson et al. May 1991 A
5046456 Heyman et al. Sep 1991 A
D321250 Jepson et al. Oct 1991 S
D321251 Jepson et al. Oct 1991 S
5064416 Newgard et al. Nov 1991 A
5065783 Ogle, II Nov 1991 A
5100394 Dudar et al. Mar 1992 A
5114408 Fleischhaker et al. May 1992 A
5122123 Vaillancourt Jun 1992 A
5135489 Jepson et al. Aug 1992 A
5154703 Bonaldo Oct 1992 A
5158554 Jepson et al. Oct 1992 A
5171234 Jepson et al. Dec 1992 A
5188620 Jepson et al. Feb 1993 A
5199947 Lopez et al. Apr 1993 A
5201717 Wyatt et al. Apr 1993 A
5203775 Frank et al. Apr 1993 A
5211638 Dudar et al. May 1993 A
5242393 Brimhall et al. Sep 1993 A
5242425 White et al. Sep 1993 A
5242432 DeFrank Sep 1993 A
5251873 Atkinson et al. Oct 1993 A
5256155 Yerlikaya et al. Oct 1993 A
5269763 Boehmer et al. Dec 1993 A
5269771 Thomas et al. Dec 1993 A
5280876 Atkins Jan 1994 A
5290254 Vaillancourt Mar 1994 A
5295657 Atkinson Mar 1994 A
5295658 Atkinson et al. Mar 1994 A
5312377 Dalton May 1994 A
5323264 Kato Jun 1994 A
5324270 Kayan et al. Jun 1994 A
5344414 Lopez et al. Sep 1994 A
5360413 Leason et al. Nov 1994 A
5401245 Haining Mar 1995 A
5402982 Atkinson et al. Apr 1995 A
5411499 Dudar et al. May 1995 A
5417673 Gordon May 1995 A
5470319 Mayer Nov 1995 A
5487731 Denton Jan 1996 A
5492147 Challender et al. Feb 1996 A
5514109 Mollenauer et al. May 1996 A
5533708 Atkinson et al. Jul 1996 A
5540661 Tomisaka et al. Jul 1996 A
5549566 Elias et al. Aug 1996 A
5549651 Lynn Aug 1996 A
5556388 Johlin, Jr. Sep 1996 A
5578059 Patzer Nov 1996 A
5602016 Isogai et al. Feb 1997 A
5609584 Gettig et al. Mar 1997 A
5616129 Mayer Apr 1997 A
5616130 Mayer Apr 1997 A
5676346 Leinsing Oct 1997 A
5677141 Isogai et al. Oct 1997 A
5685866 Lopez Nov 1997 A
5690612 Lopez et al. Nov 1997 A
5695466 Lopez et al. Dec 1997 A
5699821 Paradis Dec 1997 A
5700248 Lopez Dec 1997 A
5730418 Feith et al. Mar 1998 A
5738663 Lopez Apr 1998 A
5773272 Isogai et al. Jun 1998 A
RE35841 Frank et al. Jul 1998 E
5788675 Mayer Aug 1998 A
5797897 Jepson et al. Aug 1998 A
5820601 Mayer Oct 1998 A
5836923 Mayer Nov 1998 A
5865807 Blake, III Feb 1999 A
5873862 Lopez Feb 1999 A
5901942 Lopez May 1999 A
5928204 Lopez Jul 1999 A
5957898 Jepson et al. Sep 1999 A
5967490 Pike Oct 1999 A
5971965 Mayer Oct 1999 A
RE36587 Tanaka et al. Feb 2000 E
6019748 Lopez Feb 2000 A
6029946 Doyle Feb 2000 A
6036171 Weinheimer et al. Mar 2000 A
6039302 Cote, Sr. et al. Mar 2000 A
RE36661 Tanaka et al. Apr 2000 E
6048335 Mayer Apr 2000 A
6089541 Weinheimer et al. Jul 2000 A
6113068 Ryan Sep 2000 A
6132403 Lopez Oct 2000 A
6132404 Lopez Oct 2000 A
6146396 Konya et al. Nov 2000 A
6152900 Mayer Nov 2000 A
6162251 Kredovski Dec 2000 A
6171287 Lynn et al. Jan 2001 B1
6177037 Mayer Jan 2001 B1
6183448 Mayer Feb 2001 B1
6187476 Pyun et al. Feb 2001 B1
6210624 Mayer Apr 2001 B1
6228069 Barth et al. May 2001 B1
6245048 Fangrow, Jr. et al. Jun 2001 B1
6261268 Mayer Jul 2001 B1
6261282 Jepson et al. Jul 2001 B1
6290206 Doyle Sep 2001 B1
6299132 Weinheimer et al. Oct 2001 B1
6325782 Lopez Dec 2001 B1
6341802 Matkovich Jan 2002 B1
6344033 Jepson et al. Feb 2002 B1
6355023 Roth et al. Mar 2002 B1
6364869 Bonaldo Apr 2002 B1
6374876 Bynum Apr 2002 B2
6383168 Landau et al. May 2002 B1
6390120 Guala May 2002 B1
6390130 Guala May 2002 B1
6394983 Mayoral et al. May 2002 B1
6394992 Sjoholm May 2002 B1
6402723 Lampropoulos Jun 2002 B1
6408897 Laurent et al. Jun 2002 B1
6409707 Guala Jun 2002 B1
6409708 Wessman Jun 2002 B1
6423053 Lee Jul 2002 B1
6428520 Lopez et al. Aug 2002 B1
6440107 Trombley, III et al. Aug 2002 B1
6467732 Tsukahara Oct 2002 B2
6481756 Field et al. Nov 2002 B1
6482188 Rogers et al. Nov 2002 B1
6485472 Richmond Nov 2002 B1
6486630 Takagi Nov 2002 B2
6491668 Paradis Dec 2002 B1
6508807 Peters Jan 2003 B1
6520932 Taylor Feb 2003 B2
6536805 Matkovich Mar 2003 B2
6537258 Guala Mar 2003 B1
6539248 Moroski Mar 2003 B1
6541802 Doyle Apr 2003 B2
6543745 Enerson Apr 2003 B1
6544236 Cragg et al. Apr 2003 B1
6569118 Johnson et al. May 2003 B2
6569125 Jepson et al. May 2003 B2
RE38145 Lynn Jun 2003 E
6572590 Stevens et al. Jun 2003 B1
6572591 Mayer Jun 2003 B2
6572592 Lopez Jun 2003 B1
6581906 Pott et al. Jun 2003 B2
6585229 Cote, Sr. et al. Jul 2003 B2
6595954 Luther et al. Jul 2003 B1
6595964 Finley et al. Jul 2003 B2
6599273 Lopez Jul 2003 B1
6605076 Jepson et al. Aug 2003 B1
6609696 Enerson Aug 2003 B2
6620119 Utterberg et al. Sep 2003 B1
6626418 Kiehne Sep 2003 B2
6634033 Mizuno et al. Oct 2003 B2
6635044 Lopez Oct 2003 B2
6638244 Reynolds Oct 2003 B1
6638258 Schwartz et al. Oct 2003 B2
6651956 Miller Nov 2003 B2
6655655 Matkovich et al. Dec 2003 B1
6666839 Utterberg et al. Dec 2003 B2
6669673 Lopez Dec 2003 B2
6669681 Jepson et al. Dec 2003 B2
6673059 Guala Jan 2004 B2
6679529 Johnson et al. Jan 2004 B2
6681810 Weston Jan 2004 B2
6682509 Lopez Jan 2004 B2
6695817 Fangrow, Jr. Feb 2004 B1
6699222 Jones et al. Mar 2004 B1
6706022 Leinsing et al. Mar 2004 B1
6716187 Jorgensen et al. Apr 2004 B1
6716189 Jarvik et al. Apr 2004 B1
6722705 Korkor Apr 2004 B2
6723074 Halseth Apr 2004 B1
6726651 Robinson et al. Apr 2004 B1
6726672 Hanly et al. Apr 2004 B1
6730883 Brown et al. May 2004 B2
6745998 Doyle Jun 2004 B2
6746438 Arnissolle Jun 2004 B1
6755391 Newton et al. Jun 2004 B2
6758833 Lopez Jul 2004 B2
6770051 Hughes et al. Aug 2004 B2
6802490 Leinsing et al. Oct 2004 B2
6802836 Bouphavichith et al. Oct 2004 B2
6808161 Hishikawa Oct 2004 B1
6808509 Davey Oct 2004 B1
6811139 Hishikawa Nov 2004 B2
6814726 Lauer Nov 2004 B1
6827709 Fujii Dec 2004 B2
6827710 Mooney et al. Dec 2004 B1
6834842 Houde Dec 2004 B2
6840501 Doyle Jan 2005 B2
6843513 Guala Jan 2005 B2
6866656 Tingey et al. Mar 2005 B2
6869426 Ganem Mar 2005 B2
6871087 Hughes et al. Mar 2005 B1
6874522 Anderson et al. Apr 2005 B2
6878905 Brown et al. Apr 2005 B2
6880801 Matkovich et al. Apr 2005 B2
6883778 Newton et al. Apr 2005 B1
6893056 Guala May 2005 B2
6902207 Lickliter Jun 2005 B2
6908459 Harding et al. Jun 2005 B2
6911025 Miyahara Jun 2005 B2
6916309 Fangrow, Jr. Jul 2005 B2
6918500 Okiyama Jul 2005 B2
6932795 Lopez et al. Aug 2005 B2
6953450 Baldwin et al. Oct 2005 B2
6955669 Curutcharry Oct 2005 B2
6960198 Sarmiento Nov 2005 B2
6964406 Doyle Nov 2005 B2
6969381 Voorhees Nov 2005 B2
6972001 Emig et al. Dec 2005 B2
6974446 Hommann et al. Dec 2005 B2
6994315 Ryan et al. Feb 2006 B2
7004934 Vaillancourt Feb 2006 B2
7008406 Mayer Mar 2006 B2
7014169 Newton et al. Mar 2006 B2
7025744 Utterberg et al. Apr 2006 B2
7033339 Lynn Apr 2006 B1
7037302 Vaillancourt et al. May 2006 B2
7041087 Henderson et al. May 2006 B2
7044441 Doyle May 2006 B2
7044937 Kirwan et al. May 2006 B1
7081600 Brown et al. Jul 2006 B2
7083605 Miyahara Aug 2006 B2
7090191 Matkovich et al. Aug 2006 B2
7097209 Sparrman et al. Aug 2006 B2
7100891 Doyle Sep 2006 B2
7104520 Leinsing et al. Sep 2006 B2
RE39334 Lynn Oct 2006 E
7114701 Peppel Oct 2006 B2
7118560 Bonaldo Oct 2006 B2
7128348 Kawamura et al. Oct 2006 B2
7137974 Almasian et al. Nov 2006 B2
7140592 Phillips Nov 2006 B2
7153296 Mitchell Dec 2006 B2
7156826 Ishii et al. Jan 2007 B2
7160272 Eyal et al. Jan 2007 B1
RE39499 Racz Feb 2007 E
7172572 Diamond et al. Feb 2007 B2
7174923 Schorn et al. Feb 2007 B2
7175615 Hanly et al. Feb 2007 B2
7182313 Doyle Feb 2007 B2
7184825 Leinsing et al. Feb 2007 B2
20010045539 Doyle Nov 2001 A1
20010049508 Fangrow et al. Dec 2001 A1
20010051791 Azzolini Dec 2001 A1
20010051793 Weston Dec 2001 A1
20020007157 Azzolini Jan 2002 A1
20020024036 Rohrbough et al. Feb 2002 A1
20020032433 Lopez Mar 2002 A1
20020038114 Segura Mar 2002 A1
20020062106 Chu et al. May 2002 A1
20020082586 Finley et al. Jun 2002 A1
20020099360 Bierman Jul 2002 A1
20020108614 Schultz Aug 2002 A1
20020115981 Wessman Aug 2002 A1
20020115984 Guala Aug 2002 A1
20020117645 Kiehne Aug 2002 A1
20020128595 Weston et al. Sep 2002 A1
20020128607 Haury et al. Sep 2002 A1
20020133124 Leinsing et al. Sep 2002 A1
20020138047 Lopez Sep 2002 A1
20020143300 Trombley et al. Oct 2002 A1
20020143301 Lopez Oct 2002 A1
20020147429 Cowan et al. Oct 2002 A1
20020147431 Lopez et al. Oct 2002 A1
20020153503 Newton et al. Oct 2002 A1
20020156431 Feith et al. Oct 2002 A1
20020161334 Castellano et al. Oct 2002 A1
20020193752 Lynn Dec 2002 A1
20030028156 Juliar Feb 2003 A1
20030032940 Doyle Feb 2003 A1
20030036735 Jepson et al. Feb 2003 A1
20030050610 Newton et al. Mar 2003 A1
20030060779 Richmond Mar 2003 A1
20030060804 Vaillancourt Mar 2003 A1
20030066978 Enerson Apr 2003 A1
20030066980 Hishikawa Apr 2003 A1
20030085372 Newton May 2003 A1
20030093061 Ganem May 2003 A1
20030098430 Leinsing et al. May 2003 A1
20030105452 Mayer Jun 2003 A1
20030109853 Harding et al. Jun 2003 A1
20030120221 Vaillancourt Jun 2003 A1
20030127620 Houde Jul 2003 A1
20030141477 Miller Jul 2003 A1
20030144626 Hanson et al. Jul 2003 A1
20030144647 Miyahara Jul 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030181854 Sauvageau Sep 2003 A1
20030183795 Doyle Oct 2003 A1
20030195478 Russo Oct 2003 A1
20030199835 Leinsing et al. Oct 2003 A1
20030208165 Christensen et al. Nov 2003 A1
20030209681 Leinsing et al. Nov 2003 A1
20030216712 Kessler et al. Nov 2003 A1
20030225379 Schaffer et al. Dec 2003 A1
20030236497 Fremming et al. Dec 2003 A1
20040006330 Fangrow Jan 2004 A1
20040019344 Peterson et al. Jan 2004 A1
20040030321 Fangrow Feb 2004 A1
20040068238 Utterberg et al. Apr 2004 A1
20040068239 Utterberg Apr 2004 A1
20040073174 Lopez Apr 2004 A1
20040073176 Utterberg Apr 2004 A1
20040092886 Mayer May 2004 A1
20040102738 Dikeman et al. May 2004 A1
20040111078 Miyahara Jun 2004 A1
20040116869 Heinz et al. Jun 2004 A1
20040122418 Voorhees Jun 2004 A1
20040124388 Kiehne Jul 2004 A1
20040124389 Phillips Jul 2004 A1
20040138641 Patzer Jul 2004 A1
20040162517 Furst et al. Aug 2004 A1
20040162540 Walenciak et al. Aug 2004 A1
20040171993 Bonaldo Sep 2004 A1
20040172006 Bonaldo Sep 2004 A1
20040186458 Hiejima et al. Sep 2004 A1
20040193119 Canaud et al. Sep 2004 A1
20040199126 Harding et al. Oct 2004 A1
20040204699 Hanly et al. Oct 2004 A1
20040206924 Newton et al. Oct 2004 A1
20040210194 Bonnette et al. Oct 2004 A1
20040225274 Jansen et al. Nov 2004 A1
20040227120 Raybuck Nov 2004 A1
20040236314 Saab Nov 2004 A1
20040243065 McConnell et al. Dec 2004 A1
20040243069 Feith et al. Dec 2004 A1
20040243070 Lopez Dec 2004 A1
20040249349 Wentling Dec 2004 A1
20040254534 Bjorkman et al. Dec 2004 A1
20040260243 Rickerd Dec 2004 A1
20040260266 Cuschieri et al. Dec 2004 A1
20050010168 Kendall Jan 2005 A1
20050015070 Delnevo et al. Jan 2005 A1
20050021000 Adair et al. Jan 2005 A1
20050033267 Decaria Feb 2005 A1
20050033268 Decaria Feb 2005 A1
20050033269 Decaria Feb 2005 A1
20050038397 Newton et al. Feb 2005 A1
20050059952 Giuliano et al. Mar 2005 A1
20050087715 Doyle Apr 2005 A1
20050090805 Shaw et al. Apr 2005 A1
20050096585 Schon et al. May 2005 A1
20050107770 Schweikert et al. May 2005 A1
20050119613 Moenning et al. Jun 2005 A1
20050121638 Doyle Jun 2005 A1
20050124935 McMichael Jun 2005 A1
20050124942 Richmond Jun 2005 A1
20050124943 Yang Jun 2005 A1
20050154372 Minezaki Jul 2005 A1
20050159710 Utterberg Jul 2005 A1
20050165365 Newton et al. Jul 2005 A1
20050171487 Haury et al. Aug 2005 A1
20050209555 Middleton et al. Sep 2005 A1
20050228362 Vaillancourt Oct 2005 A1
20050256460 Rome et al. Nov 2005 A1
20050256461 DiFiore et al. Nov 2005 A1
20050261637 Miller Nov 2005 A1
20050261665 Voorhees Nov 2005 A1
20050267445 Mendels Dec 2005 A1
20060015086 Rasmussen et al. Jan 2006 A1
20060025724 Chen Feb 2006 A1
20060025751 Roy et al. Feb 2006 A1
20060027270 Truitt et al. Feb 2006 A1
20060047251 Bickford-Smith et al. Mar 2006 A1
20060074386 Wollmann Apr 2006 A1
20060089603 Truitt et al. Apr 2006 A1
20060089604 Guerrero Apr 2006 A1
20060089605 Fitzgerald Apr 2006 A1
20060111694 Fukai et al. May 2006 A1
20060129109 Shaw et al. Jun 2006 A1
20060129112 Lynn Jun 2006 A1
20060142735 Whitley Jun 2006 A1
20060149213 Raybuck Jul 2006 A1
20060161115 Fangrow Jul 2006 A1
20060173420 Fangrow Aug 2006 A1
20060178645 Peppel Aug 2006 A1
20060184139 Quigley et al. Aug 2006 A1
20060184140 Okiyama Aug 2006 A1
20060200072 Peppel Sep 2006 A1
20060200095 Steube Sep 2006 A1
20060200096 Fangrow Sep 2006 A1
20060206058 Lopez Sep 2006 A1
20060206059 Lopez Sep 2006 A1
20060211997 Fangrow Sep 2006 A1
20060211998 Fangrow Sep 2006 A1
20060211999 Fangrow Sep 2006 A1
20060212000 Fangrow Sep 2006 A1
20060212001 Fangrow Sep 2006 A1
20060212002 Fangrow Sep 2006 A1
20060212003 Fangrow Sep 2006 A1
20060212005 Fangrow Sep 2006 A1
20060212006 Fangrow et al. Sep 2006 A1
20060217671 Peppel Sep 2006 A1
20060217679 Hanly et al. Sep 2006 A1
20060217683 Patania Sep 2006 A1
20060229571 Peppel Oct 2006 A1
20060229590 Roy Oct 2006 A1
20060264842 Fangrow Nov 2006 A1
20060264843 Fangrow Nov 2006 A1
20060264844 Fangrow Nov 2006 A1
20060264845 Lopez Nov 2006 A1
20060264846 Lopez Nov 2006 A1
20060264847 Lopez Nov 2006 A1
20060264848 Fangrow Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20060264891 Lopez Nov 2006 A1
20060264892 Lopez Nov 2006 A1
20060264894 Moberg et al. Nov 2006 A1
20060264908 Ishii et al. Nov 2006 A1
20060264909 Fangrow Nov 2006 A1
20060264910 Fangrow Nov 2006 A1
20060270999 Fangrow Nov 2006 A1
20060271012 Canoud Nov 2006 A1
20060271015 Mantell Nov 2006 A1
20060271016 Fangrow Nov 2006 A1
20060276757 Fangrow Dec 2006 A1
20060276758 Fangrow Dec 2006 A1
20060287638 Aneas Dec 2006 A1
20060287639 Sharp Dec 2006 A1
20060293629 Cote et al. Dec 2006 A1
20060293640 Greco Dec 2006 A1
20070032775 Niedospial et al. Feb 2007 A1
20070032776 Skinner et al. Feb 2007 A1
20070038189 Bartholomew Feb 2007 A1
20070043334 Guala Feb 2007 A1
20070060898 Shaughnessy et al. Mar 2007 A1
20070060902 Brandenburger et al. Mar 2007 A1
20070060904 Vedrine et al. Mar 2007 A1
20070073242 Andersen et al. Mar 2007 A1
20070078393 Lynch et al. Apr 2007 A1
20070078429 Sharp Apr 2007 A1
20070083157 Belley et al. Apr 2007 A1
20070088252 Pestotnik et al. Apr 2007 A1
20070088292 Fangrow Apr 2007 A1
20070088293 Fangrow Apr 2007 A1
20070088294 Fangrow Apr 2007 A1
20070088313 Zinger et al. Apr 2007 A1
20070088324 Fangrow Apr 2007 A1
20070088325 Fangrow Apr 2007 A1
20070088327 Guala Apr 2007 A1
20070093764 Guererro Apr 2007 A1
20070100294 Sugita et al. May 2007 A1
20070112311 Harding et al. May 2007 A1
20070112312 Fangrow May 2007 A1
20070112313 Fangrow May 2007 A1
20070112314 Harding et al. May 2007 A1
20070112332 Harding et al. May 2007 A1
20070112333 Hoang et al. May 2007 A1
20070129705 Trombley et al. Jun 2007 A1
20070156112 Walsh Jul 2007 A1
20070156118 Ramsey et al. Jul 2007 A1
Foreign Referenced Citations (22)
Number Date Country
1105959 Jul 1981 CA
855319 Nov 1952 DE
8425197 Oct 1985 DE
3740269 Jun 1989 DE
0114677 Aug 1984 EP
0237321 Sep 1987 EP
0309771 Apr 1989 EP
0367549 Oct 1989 EP
0399119 Nov 1990 EP
0438909 Dec 1990 EP
0446463 Dec 1990 EP
1733749 Dec 2006 EP
2034185 Jun 1980 GB
8601712 Mar 1986 WO
8603416 Jun 1986 WO
9311828 Jun 1993 WO
9721463 Jun 1997 WO
9721464 Jun 1997 WO
9826835 Jun 1998 WO
9958186 Nov 1999 WO
0204065 Jan 2002 WO
03086528 Oct 2003 WO
Related Publications (1)
Number Date Country
20080093571 A1 Apr 2008 US
Provisional Applications (1)
Number Date Country
60862502 Oct 2006 US